Cel Sci (CVM) Liabilities and Shareholders Equity (2010 - 2026)

Cel Sci has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $17.7 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 18.8% year-over-year to $17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.1 million (down 9.61% YoY) and the FY2025 annual result came in at $28.2 million, up 4.31% from the prior year.
• Liabilities and Shareholders Equity slipped to $17.7 million in Q1 2026 per CVM's latest filing, from $22.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $64.2 million in Q1 2022 and troughed at $17.7 million in Q1 2026.
• A 5-year average of $33.2 million and a median of $28.7 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity surged 32.66% in 2022, then plunged 43.19% in 2023.
• Over 5 years, Liabilities and Shareholders Equity stood at $44.6 million in 2022, then sank by 35.57% to $28.7 million in 2023, then decreased by 10.49% to $25.7 million in 2024, then decreased by 10.91% to $22.9 million in 2025, then dropped by 22.66% to $17.7 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $17.7 million, $22.9 million, and $28.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.